Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including patients with brain metastases.

Lookup NU author(s): Dr Nicola Cresti, Dr Linda Hogarth

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Deva S, Baird RD, Cresti N, Garcia-Corbacho J, Hogarth L, Frenkel EP, Kawaguchi K, Arimura A, Donaldson K, Posner J, Sarker D, Jodrell DI, Plummer R, Spicer JF

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: ASCO Annual Meeting

Year of Conference: 2015

ISSN: 1527-7755

Publisher: American Society of Clinical Oncology

URL: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/2511?sid=7c67a5bc-4b82-4eed-aa51-49b1539226be

Series Title: Journal of Clinical Oncology

Share